- Report
- February 2025
- 185 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- November 2024
- 150 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- October 2024
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 183 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 181 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 196 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 199 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 190 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 148 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- July 2024
- 114 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- June 2024
- 220 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- January 2025
- 137 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2025
- 504 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 510 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 402 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more